Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

NCT07284758

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Berenson Cancer Center West Hollywood, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Indiana University Health Indianapolis, Indiana, United States
View Trial Details
Recruiting

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

NCT04064060

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations
  • Local Institution - 968 Los Angeles, California, United States
  • Local Institution - 971 Oakland, California, United States
  • Local Institution - 978 Stanford, California, United States
  • Local Institution - 975 Tampa, Florida, United States
View all 143 locations
View Trial Details
Recruiting

Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.

NCT06812104

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Kameda General Hospital Kamogawa, Chiba, Japan
  • University of Fukui Hospital Yoshida, Fukui, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View all 17 locations
View Trial Details
Recruiting

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

NCT06057402

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCI Health - Irvine Infusion Pharmacy ACC Irvine, California, United States
  • UC Irvine Health Orange, California, United States
  • UCI Health Orange, California, United States
  • UCHealth Poudre Valley Hospital Fort Collins, Colorado, United States
View all 33 locations
View Trial Details
Recruiting

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

NCT05722886

Conditions
Haematological Malignancy, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

NCT07007052

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Disease Attributes, +16 more
Locations
  • AMIENS - CH Amiens Picardie Site Sud Amiens, France
  • ANGERS - CHU - Maladies du sang Angers, France
  • ARGENTEUIL - Centre hospitalier Victor Dupouy Argenteuil, France
  • AVIGNON - Centre Hospitalier Avignon, France
View all 34 locations
View Trial Details
Recruiting

A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT05776472

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • Canberra Hospital Garran, Australia
View all 87 locations
View Trial Details

Related conditions